« Back
Home /
Atrial Natriuretic Peptide (ANP) (1-30), frog

Atrial Natriuretic Peptide (ANP) (1-30), frog

Item no.	RP11191-0.5
Manufacturer	GenScript
Amount	0.5 mg
Category	Peptides & Proteins Cardiovascular Research Heart Failure Myocardial Infarction Hypertension Peptides
Type	Peptides
Specific against	other
Purity	> 95%
Sequence	APRSMRRSSDCFGSRIDRIGAQSGMGCGRF ; {ALA}{PRO}{ARG}{SER}{MET}{ARG}{ARG}{SER}{SER}{ASP}{CYS}{PHE}{GLY}{SER}{ARG}{ILE}{ASP}{ARG}{ILE}{GLY}{ALA}{GLN}{SER}{GLY}{MET}{GLY}{CYS}{GLY}{ARG}{PHE}
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	peptide/RP11191-ANP_1-30_Atrial_natriuretic_peptide_frog, Atrial natriuretic peptide (ANP) is a 28 amino acid peptide that is synthesized, stored, and released by atrial myocytes in response to atrial distension, angiotensin II stimulation, endothelin, and sympathetic stimulation.</td></tr><tr><th>Purity</th><td colspan="7"> > 95% </td></tr><tr><th>Storage</th><td colspan="7"> Lyophilized powder may be stored at 4C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20C. Reconstituted product is stable for 24 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. </td></tr><tr><th>Notes</th><td colspan="7"> This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.</td></tr>
Similar products	Atrial
Available
Country of Origin	USA
Storage Conditions	Lyophilized powder may be stored at 4C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20C. Reconstituted product is stable for 24 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Description	Atrial natriuretic peptide (ANP) is a 28 amino acid peptide that is synthesized, stored, and released by atrial myocytes in response to atrial distension, angiotensin II stimulation, endothelin, and sympathetic stimulation.
Chemical Bridge	Cys11-Cys27
Notes	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.5 mg

available

Delivery expected until 9/25/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer